Anumana Entered into a Multi-Year Strategic Collaboration with Novartis to Develop ECG AI Algorithms for the Detection of Heart Disease
Related Articles
New Philips platform offers AI-powered ECG tools from outside vendors
Royal Philips has launched the Philips ECG AI Marketplace, which gives cardiac care teams access to multiple vendor offerings in one central location. The company hopes this can help clinicians…July 25, 2025
Anumana Announces Issuance of New American Medical Association CPT Category III Codes for Novel ECG AI Analysis of Cardiac Dysfunction
IT Business Net: Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced the American Medical Association (AMA) has issued new industry-first Category III Current Procedural Terminology (CPT)…July 06, 2022
How AI Is Shaping the Futureof Diagnostic Accuracy inReal-World Care
AI is transforming diagnostics by identifying subtle patterns, streamlining workflows, and accelerating time to diagnosis. This piece will explore how AI supports earlier and more accurate decision-making, the importance of…October 01, 2025
Mayo Clinic Launches Two Companies To Improve AI Diagnostic And Preventative Care
Healthcare Technology Report: Artificial Intelligence (AI) continues to improve the healthcare industry. Capitalizing on AI’s many applications, Mayo Clinic is currently launching two new ventures, Anumana and Lucem Health, in…April 28, 2021